0000948046-16-000116.txt : 20160216
0000948046-16-000116.hdr.sgml : 20160215
20160216104233
ACCESSION NUMBER: 0000948046-16-000116
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20160216
DATE AS OF CHANGE: 20160216
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: REPROS THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000897075
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 760233274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-52909
FILM NUMBER: 161424443
BUSINESS ADDRESS:
STREET 1: 2408 TIMBERLOCH PL
STREET 2: SUITE B-7
CITY: WOODLANDS
STATE: TX
ZIP: 77380
BUSINESS PHONE: 2817193400
MAIL ADDRESS:
STREET 1: 2408 TIMBERLOCH PLACE B-7
CITY: THE WOODLANDS
STATE: TX
ZIP: 77380
FORMER COMPANY:
FORMER CONFORMED NAME: REPROS THERAPEUTICS INC
DATE OF NAME CHANGE: 20060503
FORMER COMPANY:
FORMER CONFORMED NAME: ZONAGEN INC
DATE OF NAME CHANGE: 19930208
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: DEUTSCHE BANK AG\
CENTRAL INDEX KEY: 0000948046
IRS NUMBER: 132944988
STATE OF INCORPORATION: 2M
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: TAUNUSANLAGE 12 D-60325
CITY: FRANKFURT AM MAIN GE
STATE: 2M
ZIP: 00000
BUSINESS PHONE: 212 250 1540
MAIL ADDRESS:
STREET 1: TAUNUSANLAGE 12 D-60325
CITY: FRANKFURT AM MAIN
STATE: 2M
ZIP: 00000
SC 13G/A
1
reprosterm.txt
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)
REPROS THERAPEUTICS INC
--------------------------------------------------------------------------------
(NAME OF ISSUER)
Common Stock (Par Value $0.001)
--------------------------------------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
76028H209
--------------------------------------------------------------------------------
(CUSIP NUMBER)
DEcember 31, 2015
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
|x| Rule 13d-1(b)
|_| Rule 13d-1(c)
|_| Rule 13d-1(d)
--------------------------------------------------------------------------------
1. Names of Reporting Persons.
Deutsche Bank AG*
--------------------------------------------------------------------------------
2. Check the Appropriate Box If a Member of a Group
(See Instructions)
(a) |_|
(b) |_|
--------------------------------------------------------------------------------
3. SEC Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization
Federal Republic of Germany
--------------------------------------------------------------------------------
5. SOLE VOTING POWER
63,639
-------------------------------------------------------------
6. SHARED VOTING POWER
NUMBER OF
SHARES 0
BENEFICIALLY -------------------------------------------------------------
OWNED BY EACH 7. SOLE DISPOSITIVE POWER
REPORTING
PERSON WITH 63,639
-------------------------------------------------------------
8. SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
63,639
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions) |_|
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row (9)
0.23%
--------------------------------------------------------------------------------
12. Type of Reporting Person
FI
--------------------------------------------------------------------------------
* In accordance with Securities Exchange Act Release No. 39538 (January 12,
1998), this filing reflects the securities beneficially owned by the Corporate
Banking & Securities group (collectively, "CB&S") of Deutsche Bank AG and its
subsidiaries and affiliates (collectively, "DBAG"). This filing does not reflect
securities, if any, beneficially owned by any other business group of DBAG.
Consistent with Rule 13d-4 under the Securities Exchange Act of 1934 ("Act"),
this filing shall not be construed as an admission that CB&S is, for purposes of
Section 13(d) under the Act, the beneficial owner of any securities covered by
the filing. Furthermore, CB&S disclaims beneficial ownership of the securities
beneficially owned by (i) any client accounts with respect to which CB&S or its
employees have voting or investment discretion, or both, and (ii) certain
investment entities, of which CB&S is the general partner, managing general
partner, or other manager, to the extent interests in such entities are held by
persons other than CB&S.
Item 1.
(a) Name of Issuer:
REPROS THERAPEUTICS INC
(b) Address of Issuer's Principal Executive Offices:
2408 Timberloch Place, Suite B-7
The Woodlands, TX 77380
United States
Item 2.
(a) Name of Person Filing:
This statement is filed on behalf of Deutsche Bank AG
("Reporting Person").
(b) Address of the Principal Office or, if none, residence:
Taunusanlage 12
60325 Frankfurt am Main
Federal Republic of Germany
(c) Citizenship:
The citizenship of the Reporting Person is set forth on the cover page.
(d) Title of Class of Securities:
The title of the securities is common stock, $0.001 par value ("Common
Stock").
(e) CUSIP Number:
The CUSIP number of the Common Stock is set forth on the cover page.
Item 3. If this statement is filed pursuant to SS.240.13d-1(b) or 240.13d-2(b)
or (c), check whether the person filing is a:
(a) |_| Broker or dealer registered under section 15 of the Act
(15 U.S.C. 78o).
(b) |_| Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
(c) |_| Insurance company as defined in section 3(a)(19) of the Act
(15 U.S.C. 78c).
(d) |_| Investment company registered under section 8 of the Investment
Company Act of 1940 (15 U.S.C 80a-8).
(e) |_| An investment adviser in accordance with S.240.13d-1(b)(1)(ii)(E);
(f) |_| An employee benefit plan or endowment fund in accordance with
S.240.13d-1(b)(1)(ii)(F);
(g) |_| A parent holding company or control person in accordance with
S. 240.13d-1(b)(1)(ii)(G);
(h) |_| A savings associations as defined in Section 3(b) of the Federal
Deposit Insurance Act (12 U.S.C. 1813);
(i) |_| A church plan that is excluded from the definition of an investment
company under section 3(c)(14) of the Investment Company Act of
1940 (15 U.S.C. 80a-3);
(j) |X| A non-U.S. institution in accordance with Group, in accordance with
Rule 13d-1 (b)(1)(ii)(J).
(k) |_| Group, in accordance with S.240.13d-1(b)(1)(ii)(J).
Item 4. Ownership.
(a) Amount beneficially owned:
The Reporting Person owns the amount of the Common Stock as set forth
on the cover page.
(b) Percent of class:
The Reporting Person owns the percentage of the Common Stock as set
forth on the cover page.
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote
The Reporting Person has the sole power to vote or direct the
vote of the Common Stock as set forth on the cover page.
(ii) Shared power to vote or to direct the vote
The Reporting Person has the shared power to vote or direct the
vote of the Common Stock as set forth on the cover page.
(iii) Sole power to dispose or to direct the disposition of
The Reporting Person has the sole power dispose or to direct
the disposition of the Common Stock as set forth on the cover
page.
(iv) Shared power to dispose or to direct the disposition of
The Reporting Person has the shared power to dispose or
to direct the disposition of the Common Stock as set forth
on the cover page.
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following |X|.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on By the Parent Holding Company or Control Person.
Not applicable.
Item 8. Identification and Classification of Members of the Group
Not applicable.
Item 9. Notice of Dissolution of Group
Not applicable.
Item 10. Certification
By signing below I certify that, to the best of my knowledge and
belief, the foreign regulatory scheme applicable to a bank organized
under the laws of the Federal Republic of Germany is substantially
comparable to the regulatory scheme applicable to the functionally
equivalent U.S. institution. I also undertake to furnish to the
Commission staff, upon request, information that would otherwise be
disclosed in a Schedule 13D.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: February 16, 2016
Deutsche Bank AG
By: /s/ Daniela Pondeva
Name: Daniela Pondeva
Title: Assistant Vice President